vs
Side-by-side financial comparison of RYDER SYSTEM INC (R) and Stryker Corporation (SYK). Click either name above to swap in a different company.
RYDER SYSTEM INC is the larger business by last-quarter revenue ($13.1B vs $7.2B, roughly 1.8× Stryker Corporation). Stryker Corporation runs the higher net margin — 11.8% vs 0.7%, a 11.1% gap on every dollar of revenue. On growth, Stryker Corporation posted the faster year-over-year revenue change (11.4% vs 1.0%). Stryker Corporation produced more free cash flow last quarter ($1.9B vs $273.0M). Over the past eight quarters, RYDER SYSTEM INC's revenue compounded faster (102.9% CAGR vs 16.9%).
Ryder System, Inc. is an American transportation and logistics company, specializing in truck rental and leasing, fleet management, supply chain management, and transportation management. It also offers full-service leasing, rental and maintenance, used vehicle sales, transportation management, professional drivers, e-commerce fulfillment, and last-mile delivery services. The company is headquartered in Coral Gables, Florida, and operates in the United States and United Kingdom.
The Stryker is a family of eight-wheeled armored fighting vehicles derived from the Canadian LAV III, which in turn derived from the Swiss Mowag Piranha. Stryker vehicles are produced by General Dynamics Land Systems-Canada (GDLS-C) for the United States Army in a plant in London, Ontario. It has four-wheel drive (8×4) and can be switched to all-wheel drive (8×8).
R vs SYK — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $13.1B | $7.2B |
| Net Profit | $93.0M | $849.0M |
| Gross Margin | — | 64.5% |
| Operating Margin | — | 25.2% |
| Net Margin | 0.7% | 11.8% |
| Revenue YoY | 1.0% | 11.4% |
| Net Profit YoY | -5.1% | 55.5% |
| EPS (diluted) | $2.34 | $2.20 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $13.1B | — | ||
| Q4 25 | $3.2B | $7.2B | ||
| Q3 25 | $3.2B | $6.1B | ||
| Q2 25 | $3.2B | $6.0B | ||
| Q1 25 | $3.1B | $5.9B | ||
| Q4 24 | $3.2B | $6.4B | ||
| Q3 24 | $3.2B | $5.5B | ||
| Q2 24 | $3.2B | $5.4B |
| Q1 26 | $93.0M | — | ||
| Q4 25 | $132.0M | $849.0M | ||
| Q3 25 | $138.0M | $859.0M | ||
| Q2 25 | $131.0M | $884.0M | ||
| Q1 25 | $98.0M | $654.0M | ||
| Q4 24 | $135.0M | $546.0M | ||
| Q3 24 | $142.0M | $834.0M | ||
| Q2 24 | $127.0M | $825.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | 64.5% | ||
| Q3 25 | — | 63.6% | ||
| Q2 25 | — | 63.8% | ||
| Q1 25 | — | 63.8% | ||
| Q4 24 | — | 64.9% | ||
| Q3 24 | — | 64.0% | ||
| Q2 24 | — | 63.0% |
| Q1 26 | — | — | ||
| Q4 25 | 5.6% | 25.2% | ||
| Q3 25 | 6.0% | 18.7% | ||
| Q2 25 | 5.8% | 18.5% | ||
| Q1 25 | 4.3% | 14.3% | ||
| Q4 24 | 5.7% | 9.0% | ||
| Q3 24 | 5.9% | 19.7% | ||
| Q2 24 | 5.6% | 19.4% |
| Q1 26 | 0.7% | — | ||
| Q4 25 | 4.2% | 11.8% | ||
| Q3 25 | 4.4% | 14.2% | ||
| Q2 25 | 4.1% | 14.7% | ||
| Q1 25 | 3.1% | 11.1% | ||
| Q4 24 | 4.2% | 8.5% | ||
| Q3 24 | 4.5% | 15.2% | ||
| Q2 24 | 4.0% | 15.2% |
| Q1 26 | $2.34 | — | ||
| Q4 25 | $3.22 | $2.20 | ||
| Q3 25 | $3.32 | $2.22 | ||
| Q2 25 | $3.13 | $2.29 | ||
| Q1 25 | $2.27 | $1.69 | ||
| Q4 24 | $3.09 | $1.41 | ||
| Q3 24 | $3.24 | $2.16 | ||
| Q2 24 | $2.84 | $2.14 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $182.0M | $4.0B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.9B | $22.4B |
| Total Assets | — | $47.8B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $182.0M | — | ||
| Q4 25 | $198.0M | $4.0B | ||
| Q3 25 | $189.0M | $3.3B | ||
| Q2 25 | $180.0M | $2.4B | ||
| Q1 25 | $151.0M | $2.3B | ||
| Q4 24 | $154.0M | $3.7B | ||
| Q3 24 | $162.0M | $3.9B | ||
| Q2 24 | $164.0M | $1.9B |
| Q1 26 | — | — | ||
| Q4 25 | $6.8B | — | ||
| Q3 25 | $7.3B | — | ||
| Q2 25 | $7.0B | — | ||
| Q1 25 | $6.7B | — | ||
| Q4 24 | $6.7B | — | ||
| Q3 24 | $6.6B | — | ||
| Q2 24 | $6.5B | — |
| Q1 26 | $2.9B | — | ||
| Q4 25 | $3.1B | $22.4B | ||
| Q3 25 | $3.1B | $21.8B | ||
| Q2 25 | $3.1B | $21.2B | ||
| Q1 25 | $3.0B | $20.9B | ||
| Q4 24 | $3.1B | $20.6B | ||
| Q3 24 | $3.1B | $20.1B | ||
| Q2 24 | $3.1B | $19.8B |
| Q1 26 | — | — | ||
| Q4 25 | $16.4B | $47.8B | ||
| Q3 25 | $16.5B | $47.1B | ||
| Q2 25 | $16.5B | $46.3B | ||
| Q1 25 | $16.4B | $46.0B | ||
| Q4 24 | $16.7B | $43.0B | ||
| Q3 24 | $16.5B | $43.8B | ||
| Q2 24 | $16.4B | $39.1B |
| Q1 26 | — | — | ||
| Q4 25 | 2.24× | — | ||
| Q3 25 | 2.35× | — | ||
| Q2 25 | 2.27× | — | ||
| Q1 25 | 2.21× | — | ||
| Q4 24 | 2.14× | — | ||
| Q3 24 | 2.17× | — | ||
| Q2 24 | 2.09× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $583.0M | $2.1B |
| Free Cash FlowOCF − Capex | $273.0M | $1.9B |
| FCF MarginFCF / Revenue | 2.1% | 26.1% |
| Capex IntensityCapex / Revenue | 3.3% | 3.7% |
| Cash ConversionOCF / Net Profit | 6.27× | 2.52× |
| TTM Free Cash FlowTrailing 4 quarters | $595.0M | $4.3B |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $583.0M | — | ||
| Q4 25 | $749.0M | $2.1B | ||
| Q3 25 | $442.0M | $1.5B | ||
| Q2 25 | $752.0M | $1.1B | ||
| Q1 25 | $651.0M | $250.0M | ||
| Q4 24 | $558.0M | $1.9B | ||
| Q3 24 | $629.0M | $1.5B | ||
| Q2 24 | $552.0M | $633.0M |
| Q1 26 | $273.0M | — | ||
| Q4 25 | $344.0M | $1.9B | ||
| Q3 25 | $-85.0M | $1.4B | ||
| Q2 25 | $63.0M | $928.0M | ||
| Q1 25 | $137.0M | $127.0M | ||
| Q4 24 | $-201.0M | $1.7B | ||
| Q3 24 | $30.0M | $1.3B | ||
| Q2 24 | $-87.0M | $481.0M |
| Q1 26 | 2.1% | — | ||
| Q4 25 | 10.8% | 26.1% | ||
| Q3 25 | -2.7% | 22.3% | ||
| Q2 25 | 2.0% | 15.4% | ||
| Q1 25 | 4.4% | 2.2% | ||
| Q4 24 | -6.3% | 25.9% | ||
| Q3 24 | 0.9% | 23.7% | ||
| Q2 24 | -2.7% | 8.9% |
| Q1 26 | 3.3% | — | ||
| Q4 25 | 12.8% | 3.7% | ||
| Q3 25 | 16.6% | 3.1% | ||
| Q2 25 | 21.6% | 3.0% | ||
| Q1 25 | 16.4% | 2.1% | ||
| Q4 24 | 23.8% | 4.1% | ||
| Q3 24 | 18.9% | 3.1% | ||
| Q2 24 | 20.1% | 2.8% |
| Q1 26 | 6.27× | — | ||
| Q4 25 | 5.67× | 2.52× | ||
| Q3 25 | 3.20× | 1.79× | ||
| Q2 25 | 5.74× | 1.26× | ||
| Q1 25 | 6.64× | 0.38× | ||
| Q4 24 | 4.13× | 3.54× | ||
| Q3 24 | 4.43× | 1.77× | ||
| Q2 24 | 4.35× | 0.77× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
R
Segment breakdown not available.
SYK
| Medical | $1.3B | 18% |
| Endoscopy | $1.1B | 16% |
| Traumaand Extremities | $1.1B | 15% |
| Instruments | $925.0M | 13% |
| Knees | $749.0M | 10% |
| Neuro Cranial | $669.0M | 9% |
| Neurovascular | $539.0M | 8% |
| Hips | $499.0M | 7% |
| Other Orthopaedics | $267.0M | 4% |
| Spine | $8.0M | 0% |
